Mariana C. De Ponte
*
Larissa de Araújo
*The final, formatted version of the article will be published soon.
EDITORIAL article
Front. Nephrol.
Sec. Clinical Research in Nephrology
Volume 4 - 2024 |
doi: 10.3389/fneph.2024.1439950
This article is part of the Research Topic Progression of Diabetic Kidney Disease View all 5 articles
Editorial: Progression of Diabetic Kidney Disease
Provisionally accepted- University of São Paulo, São Paulo, Brazil
Keywords: Diabetic kidney disease, Albuminuria, cannabinoid type-1 receptor, oxygen stress inducible enzyme, SGLT2 inhibitors
Received: 28 May 2024; Accepted: 16 Jul 2024.
Copyright: © 2024 De Ponte and de Araújo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Mariana C. De Ponte, University of São Paulo, São Paulo, Brazil
Larissa de Araújo, University of São Paulo, São Paulo, Brazil
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.